日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Studies of the Efficacy of Low-Dose Apatinib Monotherapy as Third-Line Treatment in Patients with Metastatic Colorectal Cancer and Apatinib's Novel Anticancer Effect by Inhibiting Tumor-Derived Exosome Secretion.

低剂量阿帕替尼单药治疗转移性结直肠癌患者三线治疗的疗效研究,以及阿帕替尼通过抑制肿瘤来源外泌体分泌发挥新型抗癌作用的研究

Zhao Lingying, Yu Qiang, Gao Chunyi, Xiang Jingzhou, Zheng Bowen, Feng Yujie, Li Runyang, Zhang Wenqing, Hong Xiaoting, Zhan Yan-Yan, Xiao Li, Hu Tianhui